Common uEV biomarkers including annexin A2, HSP70, and CD9 were all present in each uEV preparation from the COVID-19-negative and COVID-19-positive participant groups, and the levels of each biomarker were generally comparable between the two groups (Figure 4A). This evidence concerns the gene CD9 and COVID-19.